{"id":"W2604893395","doi":"10.3389/fonc.2017.00067","title":"Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer","year":2017,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Docetaxel; Nivolumab; Oncology; Atezolizumab; Lung cancer; Internal medicine; Chemotherapy; Cancer; Immunotherapy; Immune checkpoint; Targeted therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001382831,0.0007135866,0.001615001,0.002114995,0.0002707106,0.001387147,0.0009825334,0.001466257,0.003811339],"category_scores_gemma":[0.002251976,0.0002849401,0.001023309,0.002110458,0.0002659154,0.001554562,0.0005980058,0.002108329,0.001577256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007548723,"about_ca_system_score_gemma":0.001352463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000906878,"about_ca_topic_score_gemma":0.003639241,"domain_scores_codex":[0.9993954,0.0001538797,0.0001127104,0.00004798005,0.0002438613,0.00004617568],"domain_scores_gemma":[0.9981527,0.0007483339,0.0003303005,0.00002895913,0.0005751256,0.0001646193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002847077,0.00008533054,0.0003225252,0.01699304,0.0002707563,0.0002573689,0.00005540837,0.0002314526,0.001283944,0.0008465798,0.2399093,0.7394596],"study_design_scores_gemma":[0.0001008454,0.0003238823,0.001162016,0.006175622,0.0006194275,0.0007669603,0.00003439412,0.00009657022,0.0002693786,0.0004726973,0.9899601,0.00001809244],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005177067,0.986645,0.0002347123,0.005162873,0.004828962,0.00003401899,0.0001807405,0.00005025457,0.002345759],"genre_scores_gemma":[0.001718576,0.9846596,0.000622974,0.005505941,0.004823851,0.00004629248,0.0004008724,0.000009306572,0.002212687],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003811339,"threshold_uncertainty_score":0.01275015,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0738078040686972,"score_gpt":0.4036445052378537,"score_spread":0.3298367011691565,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}